Trial Information
Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
Inclusion Criteria:
- Patients of at least 21 years old on day of giving consent for study
- Patients must be able and wiling to give an informed consent
- Patient with chronic HBV infection
- Patient with active hepatocellular carcinoma and chronic hepatitis B
- Healthy subjects
Exclusion Criteria:
- Patients who have co-infection with HIV or chronic hepatitis C
- Subjects with other types of cancer
Type of Study:
Observational
Study Design:
Time Perspective: Cross-Sectional
Authority:
Malaysia: Ministry of Health
Study ID:
09-317-3991
NCT ID:
NCT01310062
Start Date:
August 2010
Completion Date:
August 2012
Related Keywords:
- Hepatitis B,Chronic
- Carcinoma,Hepatocellular
- hepatocellular carcinoma
- microarray
- gene expression profiling
- biomarkers
- Carcinoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Liver Neoplasms
- Hepatitis B, Chronic
- Carcinoma, Hepatocellular